• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Improving Secondary Stroke Prevention Following Acute Ischemic Stroke: A Practice Improvement Project. (P4.287)
CONCLUSIONS: Aggressive lifestyle modification and risk factor management are cornerstones of stroke prevention. Questionnaires and checklist based systems are powerful tools to quickly gather information and assess patient participation in healthcare. In individualized stroke clinics, it is a practical tool to monitor goals of secondary stroke prevention. Further data can clarify if additional instruments like multidisciplinary stroke clinics incorporating nutrition, physical therapy and stroke counseling services will improve outcomes, compliance and reduce stroke recurrence.Disclosure: Dr. Harriott has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Harriott, A. Tags: Practice, Policy, and Ethics: Stroke, Critical Care, and Other Source Type: research

Seizures and Epilepsy after Stroke: Resources and Costs Assessment (P03.118)
CONCLUSIONS: Seizures after stroke substantially increase direct costs and resource consumption. They contribute to poor prognosis of stroke and increases mortality.Disclosure: Dr. Guekht has nothing to disclose. Dr. Mizinova has nothing to disclose. Dr. Ershov has nothing to disclose. Dr. Guz has nothing to disclose. Dr. Kaimovsky has nothing to disclose. Dr. Shpak has nothing to disclose.
Source: Neurology - February 14, 2013 Category: Neurology Authors: Guekht, A., Mizinova, M., Ershov, A., Guz, D., Kaimovsky, I., Shpak, A. Tags: P03 Epilepsy: Resources, Quality Measures, and Epidemiology Source Type: research

Is the Use of r-tPA in Mild Stroke Patients Cost-Effective? (P3.104)
CONCLUSIONS: Economic analyses based on preliminary clinical data suggest that r-tPA could be cost saving or highly cost-effective in the treatment of mild patients. Controlled clinical trials will be valuable in definitively establishing the clinical and economic value of r-tPA in mild stroke.Study Supported by: Genentech Inc.Disclosure: Dr. Guzauskas has received personal compensation for activities with Genentech, Inc. Dr. Guzauskas has received research support from Genentech, Inc. Dr. Chen has received personal compensation for activities with Genentech, Inc. as an employee. Dr. Khatri's institution has received resea...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Guzauskas, G., Chen, E., Khatri, P., Sandercock, P., Tayama, D., Veenstra, D. Tags: Cerebrovascular Disease and Interventional Neurology: t-PA Source Type: research

An electronic decision support tool for Stroke Prevention in Atrial Fibrillation (SPAF): An integrated primary-tertiary care model of care. (S47.001)
CONCLUSIONS: Given that the existing technology base is well established nationwide, it is expected that this could become a national model which would have significant benefits for patient care and healthcare costs across the country.Disclosure: Dr. Jolliffe has nothing to disclose. Dr. Rosemergy has nothing to disclose. Dr. Lanford has nothing to disclose. Dr. Abernethy has nothing to disclose. Dr. Ranta has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Jolliffe, E., Rosemergy, I., Lanford, J., Abernethy, D., Ranta, A. Tags: Cerebrovascular Disease and Interventional Neurology Source Type: research

Analysis of Inpatient Thrombophilia Testing for Adults with an Ischemic Stroke or Transient Ischemic Attack and its Impact on Clinical Management (P1.123)
Conclusions: Inpatient thrombophilia testing did not affect management in the vast majority of patients with an ischemic stroke or TIA despite a positive test result. Therefore, by avoiding inpatient testing, healthcare costs may be reduced without affecting patient care.Disclosure: Dr. Gavva has nothing to disclose. Dr. Alberts has received personal compensation for activities with AGA medical, AstraZeneca, Bayer, Pfizer, Bistol-Myers-Squibb, Boehringer Ingelheim, diaDexus, Genentech, KOS, Medicine Company, PDL biopharma, Pfizer, Photothera, Sanofi. Dr. Johnson has nothing to disclose. Dr. Sarode has received personal com...
Source: Neurology - April 3, 2016 Category: Neurology Authors: Gavva, C., Alberts, M., Johnson, M., Sarode, R. Tags: Cerebrovascular Disease: Epidemiology Source Type: research

Clinical and In-hospital Process Variables Are Associated With Hospital Length-of-Stay in Acute Ischemic Stroke Patients (P6.246)
CONCLUSIONS: For mild ischemic stroke patients, time to physical therapy evaluation (an in-hospital care process) was associated with LOS and likelihood of return to ED, whereas clinical factors (including mRS, NIHSS score, infarct location) were not. This suggests coordination of inpatient care processes, in addition to assessing and treating co-morbidities, could impact hospital LOS and, perhaps, long-term outcome.Disclosure: Dr. Kim has nothing to disclose. Dr. Conley has nothing to disclose. Dr. Kalanithi has nothing to disclose. Dr. Tai has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Kim, S., Conley, J., Kalanithi, L., Tai, W. Tags: Cerebrovascular Disease and Interventional Neurology: Thrombolysis Complications Source Type: research

An Updated Cost-Effectiveness Analysis (CEA) of r-tPA for Acute Ischemic Stroke (AIS) Treated Within 3 Hours of Symptom Onset (P4.243)
CONCLUSIONS: Economic analyses suggest that r-tPA is highly cost-effective in treatment of AIS across numerous efficacy, safety, and mortality estimates. Further research on differences in long-term mortality in disabled and non-disabled patients is needed.Study Supported by: Genentech Inc.Disclosure: Dr. Boudreau has received personal compensation for activities with Genentech, Inc. Dr. Guzauskas has received personal compensation for activities with Genentech, Inc. Dr. Guzauskas has received research support from Genentech, Inc. Dr. Tayama has received personal compensation for activities with Genentech Inc. Dr. Tayam ho...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Boudreau, D., Guzauskas, G., Tayama, D., Fagan, S., Veenstra, D. Tags: Cerebrovascular Disease and Interventional Neurology: Endovascular Neurology Source Type: research